RMD Q4 2018 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q4 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$624M+12.0% YoY

Gross Profit

$362M58.1% margin

Operating Income

$147M23.6% margin

Net Income

$110M17.6% margin

EPS (Diluted)

$0.76

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

$110M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$1.0B

Stockholders' Equity

$2.1B

Cash & Equivalents

$189M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$624M	$557M	+12.0%
Gross Profit	$362M	$324M	+12.0%
Operating Income	$147M	$127M	+15.3%
Net Income	$110M	$102M	+8.1%